Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data

被引：0
作者：
Robin Kristófi
Johan Bodegard
Viveca Ritsinger
Marcus Thuresson
David Nathanson
Thomas Nyström
Anna Norhammar
Jan W. Eriksson
机构：
[1] Uppsala University,Department of Medical Sciences, Clinical Diabetes and Metabolism
[2] BioPharmaceuticals,Cardiovascular, Renal and Metabolism, Medical Department
[3] AstraZeneca,Cardiology Unit, Department of Medicine
[4] Karolinska Institute,Department of Research and Development
[5] Region Kronoberg,Department of Medicine
[6] Statisticon AB,Department of Clinical Science and Education
[7] Karolinska Institutet,undefined
[8] Karolinska Institutet,undefined
[9] Södersjukhuset,undefined
[10] Capio St. Göran Hospital,undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Coronavirus 2019 (COVID-19); Type 1 diabetes; Type 2 diabetes; Mortality; Cardiovascular complications;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 97 条
  • [1] Wiersinga WJ(2020)Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review J Am Med Assoc 324 782-793
  • [2] Rhodes A(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan China Lancet 395 497-506
  • [3] Cheng AC(2020)COVID-19 and comorbidities: a systematic review and meta-analysis Postgrad Med 132 749-755
  • [4] Peacock SJ(2021)Comorbidities’ potential impacts on severe and non-severe patients with COVID-19: a systematic review and meta-analysis Medicine (Baltimore) 100 91-95
  • [5] Prescott HC(2020)Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis Int J Infect Dis 94 1211-1218
  • [6] Huang C(2021)Cardiovascular and renal disease burden in type 1 compared with type 2 diabetes: a two-country nationwide observational study Diabetes Care 44 82-93
  • [7] Wang Y(2021)Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study Lancet Reg Heal Eur 4 350-359
  • [8] Li X(2021)Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland Lancet Diabetes Endocrinol 9 1480-1491
  • [9] Ren L(2021)Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study Lancet Diabetes Endocrinol 9 1-11
  • [10] Zhao J(2022)Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis BMJ Nutr Prev Heal. 64 1-10
12345678910